找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Imaging Tumor Response to Therapy; Massimo Aglietta,Daniele Regge Book 2012 Springer-Verlag Italia Srl 2012 Assessment of Response.Functio

[复制链接]
楼主: PLY
发表于 2025-3-25 06:56:46 | 显示全部楼层
Gastrointestinal Stromal Tumorses from a highly prevalent tumor the “micro-GIST,” which is < 2 cm wide [1] and is estimated to occur in up to 22% of the general population, to a rare disease characterized by a tumor > 2 cm and with an annual incidence of about 15/1,000,000 [2]. While the clinical relevance of microGIST is still u
发表于 2025-3-25 08:04:59 | 显示全部楼层
Renal Cancerl increase in the incidence of this disease is 2% [1, 2]. More than 50% of RCCs are diagnosed incidentally and are asymptomatic. The classic triad of flank pain, gross hematuria, and a palpable abdominal mass is seen in very few patients (6–10%). Paraneoplastic symptoms (e.g., hypertension, weight l
发表于 2025-3-25 15:08:55 | 显示全部楼层
Liver Metastases in Colon Cancerosis in another 40–50% [1]. Although liver resection is currently the only therapy producing long-term cure, at diagnosis 80% of patients are not considered to be candidates for resection because of the size, location, and extent of their disease. Radiofrequency ablation has been proposed as an alte
发表于 2025-3-25 18:15:58 | 显示全部楼层
Neoadjuvant Therapy in Breast Cancercally, NAT was initially used in women with locally advanced breast cancer. In this setting it represented the only chance for a patient with an otherwise inoperable cancer of the breast to obtain a tumor regression that made surgery feasible. These experiences in locally advanced tumors suggested t
发表于 2025-3-25 23:24:32 | 显示全部楼层
Lung Cancer challenge. Both local relapses and distant metastases are frequent, with a 5-year survival of 3–17% for inoperable disease [2]. According to the data released by the IASLC Lung Cancer Staging Project in 2007, the 5-year survival rates for the new clinical stages were 50%, 47%, 36%, 26%, 19%, 7%, an
发表于 2025-3-26 01:47:08 | 显示全部楼层
发表于 2025-3-26 05:12:01 | 显示全部楼层
Hepatocellular Carcinomas incidence has invariably increased over the last several decades and it is expected to continue rising, although the etiological landscape, until now dominated by hepatotropic viruses, may change in favor of metabolic diseases that involve the liver [2]. HCC is, in fact, currently most often assoc
发表于 2025-3-26 10:57:29 | 显示全部楼层
https://doi.org/10.1007/978-88-470-2613-1Assessment of Response; Functional Imaging; Oncology; Radiology
发表于 2025-3-26 12:50:09 | 显示全部楼层
978-88-470-3922-3Springer-Verlag Italia Srl 2012
发表于 2025-3-26 19:30:29 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-18 16:53
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表